Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,267 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

NCT00000750

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham, Alabama, United States
  • Kaiser Permanente / UCLA Med Ctr Downey, California, United States
  • UCLA Med Ctr / Pediatric Los Angeles, California, United States
  • Harbor - UCLA Med Ctr / UCLA School of Medicine Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

NCT00000820

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States
View Trial Details
Completed

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

NCT00000865

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States
  • Bronx-Lebanon Hosp. IMPAACT CRS The Bronx, New York, United States
View Trial Details
Completed

A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

NCT00000791

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

NCT00000866

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • JHU AVEG Baltimore, Maryland, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease

NCT00000814

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham, Alabama, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • Long Beach Memorial (Pediatric) Long Beach, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
View all 68 locations
View Trial Details
Completed

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

NCT00000777

Conditions
Blood-Borne Infections, Communicable Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Yale Univ Med School New Haven, Connecticut, United States
  • Vanderbilt Univ Hosp Nashville, Tennessee, United States
View Trial Details
Completed

A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women

NCT00000864

Conditions
Blood-Borne Infections, Communicable Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
View all 13 locations
View Trial Details

Related conditions